Ilex Capital Partners’s Carter's CRI Stock Holding History

Ilex Capital Partners’s Portfolio CRI Stock Details CRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-34,157	Closed	-$1.4M	–	183
2025 Q1	$1.4M	Buy	+34,157	New	+$1.64M	0.06%	155

Other funds holding CRI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RWWM Inc Rocklin, California $1.35B AUM 9.17% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ilex Capital Partners's CRI Position: Q2 2025 in Review

Ilex Capital Partners sold out of Carter's (CRI) in Q2 2025, closing a stake of 34,157 shares — an estimated $1.4M sold.

Ilex Capital Partners first reported a position in CRI in Q1 2025 and held it in 1 quarter. The position peaked at $1.4M in Q1 2025. 268 funds tracked by Wall St. Rank hold CRI as of Q2 2025.

Ilex Capital Partners reported no remaining Carter's position as of Q2 2025 after selling out during the quarter.
Ilex Capital Partners sold 34,157 Carter's shares in Q2 2025, an estimated $1.4M.
Ilex Capital Partners first reported a position in Carter's in Q1 2025 and held it in 1 quarter.
Ilex Capital Partners's Carter's position peaked at $1.4M in Q1 2025.
268 funds tracked by Wall St. Rank held Carter's as of Q2 2025.

Based on Ilex Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.